European Companies Search Engine
Member of the Executive Board: Thomas Siklosi · Authorized signatory (ppa) (6) · Capital: €30M · Company statute Hrb 16 Oct 2017 German Trade Register Announcements, Germany
Overview
Text
HRB 731612: Rentschler Biopharma SE,
Laupheim, Erwin-Rentschler-Straße 21, 88471 Laupheim
. The Annual General Meeting of September 21, 2017 approved the amendment of the Articles of Association in Sections 3 (Subscribed Capital) and Section 4 (1) (shares). The share capital is increased by EUR 29,830,000.00 to EUR 30,000,000.00 by resolution of the Annual General Meeting on September 21, 2017. The capital increase has been carried out. Capital now: EUR 30,000,000.00. Appointed a.s. Board Member: Siklosi, Thomas, Mietingen, *??.??.????. Total prokura together with a member of the Board of Management or another authorized representative: Dr. Froneck, Thomas, Balingen, *??.??.????; ?????, ????, Constancy, *??.??.????; Dr. ???????, ?????? ??????, Laupheim, *??.??.????; Dr. ???????, ????? ????????, Brühl, *??.??.????; ???????, ???, Laupheim, *??.??.????; Dr. ????????????, ?????????, Pöcking, *??.??.????. As not registered, the increased share capital is paid in kind on the basis of the documents submitted to the court.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Rentschler Biopharma SE, Laupheim, Germany.